Fecal Incontinence Therapy


InterStim® Therapy (SNS) is an FDA-approved neurostimulation therapy that targets the communication problem between the brain and the nerves that control bowel function. The Food and Drug Administration approved sacral nerve stimulation for fecal incontinence in 2011.

InterStim Therapy is designed to minimize the symptoms of bowel incontinence, including the leakage of liquid or solid stools. Prior to undergoing a permanent implantation of the neurostimulation device, patients undergo a trial assessment, which allows them to try neurostimulation to see if it is an appropriate treatment without making a long-term commitment. The trial can take a few to several weeks to complete.